4.6 Article

Anaesthetic Impairment of Immune Function Is Mediated via GABAA Receptors

期刊

PLOS ONE
卷 6, 期 2, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0017152

关键词

-

资金

  1. Medical Research Council [79588]
  2. Wellcome Trust [08195]
  3. Association of Anaesthetists of Ireland
  4. Biotechnology and Biological Sciences Research Council
  5. Royal College of Anaesthetists
  6. Queen's College, Cambridge
  7. Evelyn Trust
  8. Association of Anaesthetists of Great Britain
  9. Medical Research Council [G0001354, G84/6409, G1000183B, G0801161, G0001354B, MC_U105184294, G0401569, G9800943] Funding Source: researchfish
  10. MRC [MC_U105184294, G0401569, G84/6409, G0801161, G9800943] Funding Source: UKRI

向作者/读者索取更多资源

Background: GABA(A) receptors are members of the Cys-loop family of neurotransmitter receptors, proteins which are responsible for fast synaptic transmission, and are the site of action of wide range of drugs [1]. Recent work has shown that Cys-loop receptors are present on immune cells, but their physiological roles and the effects of drugs that modify their function in the innate immune system are currently unclear [2]. We are interested in how and why anaesthetics increase infections in intensive care patients; a serious problem as more than 50% of patients with severe sepsis will die [3-6]. As many anaesthetics act via GABA(A) receptors [7], the aim of this study was to determine if these receptors are present on immune cells, and could play a role in immunocompromising patients. Principal Findings: We demonstrate, using RT-PCR, that monocytes express GABA(A) receptors constructed of alpha 1, alpha 4, beta 2, gamma 1 and/or delta subunits. Whole cell patch clamp electrophysiological studies show that GABA can activate these receptors, resulting in the opening of a chloride-selective channel; activation is inhibited by the GABA(A) receptor antagonists bicuculline and picrotoxin, but not enhanced by the positive modulator diazepam. The anaesthetic drugs propofol and thiopental, which can act via GABA(A) receptors, impaired monocyte function in classic immunological chemotaxis and phagocytosis assays, an effect reversed by bicuculline and picrotoxin. Significance: Our results show that functional GABA(A) receptors are present on monocytes with properties similar to CNS GABA(A) receptors. The functional data provide a possible explanation as to why chronic propofol and thiopental administration can increase the risk of infection in critically ill patients: their action on GABA(A) receptors inhibits normal monocyte behaviour. The data also suggest a potential solution: monocyte GABA(A) receptors are insensitive to diazepam, thus the use of benzodiazepines as an alternative anesthetising agent may be advantageous where infection is a life threatening problem.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nutrition & Dietetics

SCFA: mechanisms and functional importance in the gut

Camille Martin-Gallausiaux, Ludovica Marinelli, Herve M. Blottiere, Pierre Larraufie, Nicolas Lapaque

Summary: This article discusses the mechanisms and impact of short-chain fatty acids (SCFA) on gut functions, host immunity, and human health. SCFA, derived from bacterial fermentation of dietary fibers, serve as important fuels for intestinal epithelial cells and modulate various functions to impact intestinal homeostasis.

PROCEEDINGS OF THE NUTRITION SOCIETY (2021)

Article Biophysics

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

J. Loke, M. Labopin, C. Craddock, D. Niederwieser, J. Cornelissen, B. Afansayev, P. Jindra, J. Maertens, D. Blaise, K. Boriskina, M. Gramatzki, A. Ganser, B. Savani, M. Mohty, A. Nagler

Summary: A study of 937 AML patients undergoing transplantation from a mismatched unrelated donor found that patient age, adverse karyotype, and CMV seropositivity were correlated with decreased LFS and OS. There was no significant difference in LFS or OS between patients transplanted from donors mismatched at different HLA loci, but HLA-A mismatched transplants were associated with higher rates of acute GVHD and NRM. Patient CMV seropositivity was linked to increased NRM and acute GVHD, as well as reduced LFS and OS.

BONE MARROW TRANSPLANTATION (2021)

Article Oncology

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Charles Craddock, Aimee Jackson, Justin Loke, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria Gilleece, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley, Keith Wheatley, Rachel Protheroe, Paresh Vyas, Ann Hunter, Anne Parker, Keith Wilson, Jiri Pavlu, Jenny Byrne, Richard Dillon, Naeem Khan, Nicholas McCarthy, Sylvie D. Freeman

Summary: The intensified RIC conditioning regimen, FLAMSA-Bu, did not improve outcomes for adults undergoing transplantation for high-risk AML or MDS, regardless of pretransplant MRD status. Pretransplant detectable MRD was associated with disease relapse, but acquisition of full donor T-cell chimerism improved overall survival.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Immunology

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?

Justin Loke, Richard Buka, Charles Craddock

Summary: While most AML patients achieve complete remission with intensive chemotherapy, many face a risk of relapse if treated with chemotherapy alone. Allogeneic stem cell transplant has become a key treatment strategy for AML patients, especially for those in first complete remission and advanced stages. Despite a decrease in transplant-related mortality, there remains a need to address the risk of disease relapse.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia

Justin Loke, Hrushikesh Vyas, Charles Craddock

Summary: AML is the most common indication for allo-SCT worldwide, with advancements in risk stratification, donor availability, and conditioning regimens expanding transplant access for high risk patients. Disease relapse remains the top cause of transplant failure, highlighting the need for novel strategies to reduce recurrence risk.

FRONTIERS IN ONCOLOGY (2021)

Editorial Material Hematology

Unravelling the apoptotic machinery in CMML

Justin Loke, Peter N. Cockerill

Summary: The study demonstrates that monocytic cells from CMML patients are vulnerable to synergistic inhibition of the antiapoptotic protein MCL-1 and the RAS/MAPK signaling pathway kinases MEK1 and MEK2.
Letter Hematology

Non-pharmacological supportive-care interventions in acute myeloid leukaemia: a review of randomised controlled trials

Dominic O'Connor, Justin Loke, Malcolm Brown, Simon J. Stanworth, Annie Young, Gillian Prue

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Article Hematology

Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy

Justin Loke, Marlen Metzner, Rebecca Boucher, Aimee Jackson, Louise Hopkins, Jiri Pavlu, Eleni Tholouli, Mark Drummond, Andy Peniket, Rebecca Bishop, Sonia Fox, Paresh Vyas, Charles Craddock

Summary: The ROMAZA trial established the maximum tolerated dose of combined ROM/AZA therapy for AML patients, with ROM 12 mg/m(2) on Days 8 and 15, and AZA 75 mg/m(2) administered for 7/28 day cycle. Among patients treated at the maximum tolerated dose, 23.7% were classified as responders by Cycle 6. Correlative next-generation sequencing studies provided important insights into therapy resistance.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Neurosciences

Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response

Zehra Esra Ilhan, Vincent Brochard, Nicolas Lapaque, Stephane Auvin, Patricia Lepage

Summary: Anti-seizure medications can affect the gut microbiota and have different impacts on the growth of gut bacterial strains. The toxicity of medication ingredients varies and can also affect gut epithelial cells. Gut microbial metabolites may play a role in mediating the interaction between medications and epithelial cells.

NEUROBIOLOGY OF DISEASE (2022)

Article Immunology

Glucose but Not Fructose Alters the Intestinal Paracellular Permeability in Association With Gut Inflammation and Dysbiosis in Mice

Xufei Zhang, Magali Monnoye, Mahendra Mariadassou, Fabienne Beguet-Crespel, Nicolas Lapaque, Christine Heberden, Veronique Douard

Summary: The study revealed different impacts of fructose and glucose intake on mice, with glucose leading to increased adiposity, glucose intolerance, and intestinal permeability, while fructose resulted in elevated IL6 levels. The research also identified the potential roles of microbiota composition and inflammatory factors in gut barrier function and inflammation.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Additional cytogenetic features determines outcome in patients allografted for TP53 mutant acute myeloid leukemia

Justin Loke, Myriam Labopin, Charles Craddock, Jan J. Cornelissen, Helene Labussiere-Wallet, Eva Maria Wagner-Drouet, Gwendolyn Van Gorkom, Nicolaas P. M. Schaap, Nicolaus M. Kroger, Joan Hendrik Veelken, Montserrat Rovira, Anne Lise Menard, Gesine Bug, Ali Bazarbachi, Sebastian Giebel, Eolia Brissot, Arnon Nagler, Jordi Esteve, Mohamad Mohty

Summary: This study found that TP53 mutations are associated with unfavorable outcomes in AML patients with intermediate or adverse-risk cytogenetics. However, in patients without co-occurring 17p- and/or complex karyotype mutations, the adverse effect of TP53 mutations on allogeneic stem cell transplantation is not evident.

CANCER (2022)

Article Gastroenterology & Hepatology

Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway

Camille Martin-Gallausiaux, Diego Garcia-Weber, Amandine Lashermes, Pierre Larraufie, Ludovica Marinelli, Veronica Teixeira, Alice Rolland, Fabienne Beguet-Crespel, Vincent Brochard, Timothe Quatremare, Alexandre Jamet, Joel Dore, Scott D. Gray-Owen, Herve M. Blottiere, Cecile Arrieumerlou, Nicolas Lapaque

Summary: The gut microbiota has an impact on the health of the host through interactions with intestinal epithelial cells. It has been found that the commensal bacterium A. muciniphila promotes intestinal homeostasis by activating the ALPK1/TIFA/TRAF6 axis, a pathway associated with innate immunity.

GUT MICROBES (2022)

Article Hematology

Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes

Justin Loke, Vinit Upasani, Charlotte Gaskell, Sonia Fox, Rachel Fletcher, Catherine Thomas, Louise Hopkins, Anita Kumari, Tina Tang, Emily Yafai, Rebecca Boucher, Victoria Homer, Arpad Toth, Y. L. Tracey Chan, Katie Randall, Tom Rider, Jenny O'Nions, Victoria Drew, Arvind Pillai, Moez Dungarwalla, Duncan Murray, Anjum Khan, Farooq Wandroo, Sally Moore, Pramila Krishnamurthy, Ya-Wen Jessica Huang, Steve Knapper, Jenny Byrne, Rui Zhao, Charles Craddock, Helen Parry, Paul Moss, Simon J. Stanworth, David M. Lowe

Summary: Limited data exist on the efficacy of COVID-19 vaccination in patients with AML/MDS-EB2. A prospective study found detectable antibodies against SARS-COV-2 spike antigen in all post-vaccine samples. T-cell reactivity to SARS-COV-2 spike protein was only seen in a subset of patients, and disease response and age were predictors of poor T-cell response.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Hematology

Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS

Justin Loke, Nicholas McCarthy, Aimee Jackson, Shamyla Siddique, Andrea Hodgkinson, John Mason, Charles Crawley, Maria Gilleece, Andrew Peniket, Rachel Protheroe, Rahuman Salim, Eleni Tholouli, Keith Wilson, Georgia Andrew, Richard Dillon, Naeem Khan, Victoria Potter, Pramila Krishnamurthy, Charles Craddock, Sylvie Freeman

Summary: This study reports the prognostic impact of biomarkers including MRD, T-cell chimerism, and blast HLA-DR expression in AML/MDS patients receiving allogeneic stem-cell transplant. MRD positivity is associated with reduced overall survival, while MRD is infrequent and does not affect the outcome in patients with full donor T-cell chimerism.

BLOOD ADVANCES (2023)

Meeting Abstract Biophysics

Impact of Co-Occurring Cytogenetic Abnormalities on Transplant Outcome of TP53 Mutant Acute Myeloid Leukaemia: Report From The ALWP of The EBMT Abstracts

Justin Loke, Myriam Labopin, Charles Craddock, Jan J. Cornelissen, Helene Labussiere-Wallet, Eva Maria Wagner-Drouet, Gwendolyn Van Gorkom, Nicolaas Schaap, Nicolaus Kroeger, Joan Hendrik Veelken, Montserrat Rovira, Herve Tilly, Hans Martin, Gesine Bug, Ali Bazarbachi, Sebastian Giebel, Eolia Brissot, Arnon Nagler, Jordi Esteve, Mohamad Mohty

BONE MARROW TRANSPLANTATION (2021)

暂无数据